HIPK2 and acute myeloid leukemia: The expression of circ‐HIPK2 in APL patients was found to be dramatically less than that in normal peripheral blood mononuclear cells (PBMCs) or other AML subtypes, suggesting circ‐HIPK2 as a potential biomarker for APL.34